Jay Sarup
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, Glycosylation and Glycoproteins Research, Chronic Lymphocytic Leukemia Research, HIV/AIDS drug development and treatment
Most-Cited Works
- → Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu(1992)760 cited
- → Monoclonal antibody therapy of human cancer: Taking the HER2 protooncogene to the clinic(1991)295 cited
- → Direct Interaction of a Ligand for the erb B2 Oncogene Product with the EGF Receptor and p185 erb B2(1990)277 cited
- Characterization of an anti-p185HER2 monoclonal antibody that stimulates receptor function and inhibits tumor cell growth.(1991)
- → p185HER2 signal transduction in breast cancer cells(1991)88 cited
- Identification of the mechanism of activation of 9-beta-D-arabinofuranosyladenine in human lymphoid cells using mutants deficient in nucleoside kinases.(1981)
- → Identification of purine deoxyribonucleoside kinases from human leukemia cells: substrate activation by purine and pyrimidine deoxyribonucleosides(1987)56 cited
- The extracellular domain of HER2/neu is a potential immunogen for active specific immunotherapy of breast cancer.(1990)
- Decreased progesterone binding and attenuated progesterone action in cultured human breast carcinoma cells treated with epidermal growth factor.(1988)
- → 5,7-Dimethoxy-3-(4-Pyridinyl)Quinoline Is a Potent and Selective Inhibitor of Human Vascular .beta.-Type Platelet-Derived Growth Factor Receptor Tyrosine Kinase(1994)41 cited